Zimbabwe has rejected a major American health deal worth $367m (£272m) over five years due to the United States' demand for sensitive data.
The decision became public after a official document dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".
A government spokesman has since clarified that the US was demanding access to biological samples for research and commercial gain while was not willing to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged further talks to secure a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Broader Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were raised about the security of citizens' health data.
After returning to office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost transparency and responsibility.
As per reports, 16 nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to share its genetic material and health information for a long time, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.
"In essence, our country would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our citizens if a new disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks previously established via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This framework is intended to ensure that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to continued discussions with our US partners on how future co-operation might be arranged in a manner that respects the sovereignty and dignity of each country."
Health Experts Reaction
Medical experts expressed it acknowledged the official position, but urged that negotiations should continue given that a large portion of the country's HIV programmes were funded by international support.
"If specific concerns exist, such as those relating to information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group commented.
The situation emphasises the complex challenges between receiving vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.